Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 11, 2023, titled "Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program".
Sun Pharmaceutical Industries Limited Press Release Jan 11 2023
Filed with NSE · · 3 pages · English
Watch Sun Pharmaceutical Industries' latest callSun Pharmaceutical Industries (NSE:SUNPHARMA) Q2 2027 Earnings Call · Replay · Oct 30Read the transcript of Sun Pharmaceutical Industries (NSE:SUNPHARMA) Q2 2027 Earnings CallRelease
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of neonatal seizures
- Press Release Nov 18 2022
- Press Release Nov 09 2022
- Press Release Nov 01 2022
- Press Release Oct 11 2022
Later from Sun Pharmaceutical Industries
- Press Release Jan 17 2023
- Press Release Jan 25 2023
- Press Release Jan 30 2023
- Press Release Jan 31 2023
- Press Release Feb 10 2023
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries